SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. [electronic resource]
Producer: 20051110Description: 4959-68 p. digitalISSN:- 0264-410X
- Administration, Oral
- Animals
- Antibodies, Viral -- blood
- Bacterial Vaccines -- administration & dosage
- Escherichia coli Proteins
- Immunization Schedule
- Immunization, Secondary
- Immunoglobulin G -- blood
- Injections, Intramuscular
- Injections, Intraperitoneal
- Interferon-gamma -- analysis
- Interleukin-4 -- analysis
- Male
- Membrane Glycoproteins -- administration & dosage
- Mice
- Mice, Inbred BALB C
- Models, Animal
- Neutralization Tests
- Severe acute respiratory syndrome-related coronavirus -- immunology
- Severe Acute Respiratory Syndrome -- prevention & control
- Spike Glycoprotein, Coronavirus
- Vaccines, DNA -- administration & dosage
- Vaccines, Synthetic -- administration & dosage
- Viral Envelope Proteins -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.